Victory Capital Management Inc. Has $21.72 Million Position in Evolent Health, Inc. (NYSE:EVH)

Victory Capital Management Inc. lessened its position in Evolent Health, Inc. (NYSE:EVH) by 16.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 657,518 shares of the technology company’s stock after selling 127,843 shares during the period. Victory Capital Management Inc. owned about 0.57% of Evolent Health worth $21,718,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of the company. Vanguard Group Inc. grew its holdings in Evolent Health by 2.7% during the third quarter. Vanguard Group Inc. now owns 10,594,640 shares of the technology company’s stock worth $288,492,000 after purchasing an additional 274,288 shares during the period. Wellington Management Group LLP boosted its stake in shares of Evolent Health by 11.9% during the 3rd quarter. Wellington Management Group LLP now owns 4,239,198 shares of the technology company’s stock worth $115,433,000 after acquiring an additional 449,664 shares during the period. Rock Springs Capital Management LP increased its holdings in shares of Evolent Health by 1.6% during the 3rd quarter. Rock Springs Capital Management LP now owns 3,865,000 shares of the technology company’s stock worth $105,244,000 after acquiring an additional 61,500 shares during the last quarter. RA Capital Management L.P. bought a new stake in Evolent Health in the 3rd quarter valued at $74,520,000. Finally, Bank of New York Mellon Corp raised its stake in Evolent Health by 8.7% in the 3rd quarter. Bank of New York Mellon Corp now owns 1,655,609 shares of the technology company’s stock worth $45,082,000 after purchasing an additional 133,038 shares in the last quarter.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the stock. JPMorgan Chase & Co. dropped their price target on shares of Evolent Health from $53.00 to $52.00 and set an “overweight” rating for the company in a research report on Friday, March 15th. Citigroup started coverage on Evolent Health in a report on Monday, April 22nd. They issued a “buy” rating and a $40.00 price objective for the company. JMP Securities increased their target price on Evolent Health from $37.00 to $38.00 and gave the stock a “market outperform” rating in a report on Friday, February 23rd. Oppenheimer started coverage on Evolent Health in a research report on Friday, March 1st. They issued an “outperform” rating and a $45.00 price target on the stock. Finally, Canaccord Genuity Group reduced their price objective on shares of Evolent Health from $45.00 to $44.00 and set a “buy” rating on the stock in a research note on Thursday, March 28th. One analyst has rated the stock with a sell rating, one has issued a hold rating and eleven have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $42.70.

Evolent Health Stock Down 1.2 %

Shares of NYSE EVH opened at $27.29 on Thursday. The company has a 50 day simple moving average of $31.02 and a 200 day simple moving average of $30.26. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.01 and a quick ratio of 1.01. Evolent Health, Inc. has a 1 year low of $23.33 and a 1 year high of $35.83. The firm has a market cap of $3.15 billion, a PE ratio of -21.49 and a beta of 1.57.

Evolent Health (NYSE:EVH) last released its quarterly earnings results on Thursday, February 22nd. The technology company reported $0.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.02 by $0.13. Evolent Health had a negative net margin of 5.76% and a positive return on equity of 6.60%. The firm had revenue of $556.06 million during the quarter, compared to the consensus estimate of $541.87 million. On average, research analysts forecast that Evolent Health, Inc. will post 0.87 EPS for the current year.

Evolent Health Company Profile

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.